Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$0.55 - $0.82 $2,116 - $3,155
3,848 New
3,848 $2,000
Q3 2022

Nov 09, 2022

BUY
$0.94 - $2.56 $1,316 - $3,584
1,400 Added 790.96%
1,577 $2,000
Q4 2021

Feb 11, 2022

BUY
$5.69 - $7.83 $34 - $46
6 Added 3.51%
177 $1,000
Q3 2021

Nov 12, 2021

SELL
$7.88 - $14.0 $2,364 - $4,200
-300 Reduced 63.69%
171 $1,000
Q2 2021

Aug 10, 2021

SELL
$13.81 - $23.25 $12,069 - $20,320
-874 Reduced 64.98%
471 $7,000
Q1 2021

May 12, 2021

BUY
$17.65 - $24.16 $23,739 - $32,495
1,345 New
1,345 $28,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.